- Home
- WYY vs NSPR Comparison
WYY vs NSPR Comparison
Compare WYY & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- NSPR
- Stock Information
- Founded
- WYY 1991
- NSPR 2005
- Country
- WYY United States
- NSPR Israel
- Employees
- WYY N/A
- NSPR N/A
- Industry
- WYY EDP Services
- NSPR Medical/Dental Instruments
- Sector
- WYY Technology
- NSPR Health Care
- Exchange
- WYY Nasdaq
- NSPR Nasdaq
- Market Cap
- WYY 54.9M
- NSPR 63.0M
- IPO Year
- WYY 1998
- NSPR N/A
- Fundamental
- Price
- WYY $4.87
- NSPR $2.87
- Analyst Decision
- WYY Strong Buy
- NSPR Strong Buy
- Analyst Count
- WYY 1
- NSPR 2
- Target Price
- WYY $7.00
- NSPR $4.75
- AVG Volume (30 Days)
- WYY 123.8K
- NSPR 33.6K
- Earning Date
- WYY 11-13-2024
- NSPR 11-12-2024
- Dividend Yield
- WYY N/A
- NSPR N/A
- EPS Growth
- WYY N/A
- NSPR N/A
- EPS
- WYY N/A
- NSPR N/A
- Revenue
- WYY $133,124,648.00
- NSPR $6,821,000.00
- Revenue This Year
- WYY $25.94
- NSPR $13.36
- Revenue Next Year
- WYY $13.22
- NSPR $49.64
- P/E Ratio
- WYY N/A
- NSPR N/A
- Revenue Growth
- WYY 31.67
- NSPR 24.70
- 52 Week Low
- WYY $1.83
- NSPR $1.81
- 52 Week High
- WYY $6.25
- NSPR $3.42
- Technical
- Relative Strength Index (RSI)
- WYY 50.68
- NSPR 49.22
- Support Level
- WYY $3.88
- NSPR $2.80
- Resistance Level
- WYY $4.97
- NSPR $3.06
- Average True Range (ATR)
- WYY 0.52
- NSPR 0.16
- MACD
- WYY -0.14
- NSPR -0.03
- Stochastic Oscillator
- WYY 41.77
- NSPR 17.50
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically the company generates a majority of its revenue from the United States and rest from Europe.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.